American Journal of Neuroradiology 21:702-706 (4 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
a From the Unit of Clinical Neuroimmunology, Department of Neurology (M.T., J.R., P.D.-V., L.B., C.B., X.M.), and the Magnetic Resonance Unit (I.D.I.), Department of Radiology (A.R., M.J.M., E.G., J.C.), Vall d'Hebron University Hospitals, Barcelona, Spain.
BACKGROUND AND PURPOSE: Various authors have developed criteria to classify MR imaging findings that suggest the possibility of multiple sclerosis. The purpose of this study was to evaluate and compare the capacity of three sets of MR imaging criteria for predicting the conversion of isolated demyelinating syndromes to clinically definite multiple sclerosis.
METHODS: Seventy patients with clinically isolated neurologic symptoms suggestive of multiple sclerosis were prospectively studied with MR imaging. The MR imaging findings were evaluated by two independent neuroradiologists who were blinded to clinical follow-up data. Based on the clinical outcome at follow-up (presence of a second attack that established clinically definite multiple sclerosis), the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the criteria proposed by Paty et al, Fazekas et al, and Barkhof et al were calculated.
RESULTS: Clinically definite multiple sclerosis developed in 22 (31%) patients after a mean follow-up time of 28.3 months. The criteria proposed by Paty et al and those proposed by Fazekas et al showed identical results: sensitivity, 86%; specificity, 54%; accuracy, 64%; positive predictive value, 46%; and negative predictive value, 89%. The criteria proposed by Barkhof et al showed the following: sensitivity, 73%; specificity, 73%; accuracy, 73%; positive predictive value, 55%; and negative predictive value, 85%.
CONCLUSION: The four dichotomized MR imaging parameters proposed by Barkhof et al are more specific and accurate than the criteria proposed by Paty et al or Fazekas et al for predicting conversion to clinically definite multiple sclerosis.
This article has been cited by other articles:
![]() |
X. Montalban, M. Tintore, J. Swanton, F. Barkhof, F. Fazekas, M. Filippi, J. Frederiksen, L. Kappos, J. Palace, C. Polman, et al. MRI criteria for MS in patients with clinically isolated syndromes Neurology, February 2, 2010; 74(5): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pelayo, X. Montalban, T. Minoves, D. Moncho, J. Rio, C. Nos, C. Tur, J. Castillo, A. Horga, M. Comabella, et al. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Multiple Sclerosis, January 1, 2010; 16(1): 55 - 61. [Abstract] [PDF] |
||||
![]() |
M. Nakamura, H. Houzen, M. Niino, K. Tanaka, and H. Sasaki Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan Multiple Sclerosis, December 1, 2009; 15(12): 1450 - 1458. [Abstract] [PDF] |
||||
![]() |
X. Montalban, J. Sastre-Garriga, M. Filippi, Z. Khaleeli, N. Tellez, M. Vellinga, C. Tur, B. Brochet, F. Barkhof, M. Rovaris, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal Multiple Sclerosis, December 1, 2009; 15(12): 1459 - 1465. [Abstract] [PDF] |
||||
![]() |
N. Jafari, K. L. Kreft, H. Z. Flach, A. C.J.W. Janssens, and R. Q. Hintzen Callosal lesion predicts future attacks after clinically isolated syndrome Neurology, December 1, 2009; 73(22): 1837 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Moraal, C. Pohl, B. M. J. Uitdehaag, C. H. Polman, G. Edan, M. S. Freedman, H.-P. Hartung, L. Kappos, D. H. Miller, X. Montalban, et al. Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study Arch Neurol, November 1, 2009; 66(11): 1345 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Young, S. Quinn, M. Hurrell, and B. Taylor Clinically isolated acute transverse myelitis: prognostic features and incidence Multiple Sclerosis, November 1, 2009; 15(11): 1295 - 1302. [Abstract] [PDF] |
||||
![]() |
C-P Lo, H-W Kao, S-Y Chen, C-J Hsueh, W-C Lin, W-L Hsu, D-K Wu, and G-C Liu Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1107 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goodin and D. Bates Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode Multiple Sclerosis, October 1, 2009; 15(10): 1175 - 1182. [Abstract] [PDF] |
||||
![]() |
A Siva, S Saip, A Altintas, A Jacob, B. Keegan, and O. Kantarci Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease Multiple Sclerosis, August 1, 2009; 15(8): 918 - 927. [Abstract] [PDF] |
||||
![]() |
J Rio, J Castillo, A Rovira, M Tintore, J Sastre-Garriga, A Horga, C Nos, M Comabella, X Aymerich, and X Montalban Measures in the first year of therapy predict the response to interferon {beta} in MS Multiple Sclerosis, July 1, 2009; 15(7): 848 - 853. [Abstract] [PDF] |
||||
![]() |
C. Lebrun, C. Bensa, M. Debouverie, S. Wiertlevski, D. Brassat, J. de Seze, L. Rumbach, J. Pelletier, P. Labauge, B. Brochet, et al. Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients Arch Neurol, July 1, 2009; 66(7): 841 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al. A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis Arch Neurol, May 1, 2009; 66(5): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freedman, J Laks, N Dotan, R. Altstock, A Dukler, and C. Sindic Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event Multiple Sclerosis, April 1, 2009; 15(4): 422 - 430. [Abstract] [PDF] |
||||
![]() |
B. L. Banwell Into the looking glass: Predicting MS in children experiencing a first demyelinating event Neurology, September 23, 2008; 71(13): 962 - 963. [Full Text] [PDF] |
||||
![]() |
C Tur, M Tintore, A Rovira, C Nos, J Rio, N Tellez, I Galan, H Perkal, M Comabella, J Sastre-Garriga, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis Multiple Sclerosis, June 1, 2008; 14(5): 631 - 635. [Abstract] [PDF] |
||||
![]() |
M. Simo, P. Barsi, and Z. Aranyi Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria Multiple Sclerosis, May 1, 2008; 14(4): 472 - 478. [Abstract] [PDF] |
||||
![]() |
C Lebrun, C Bensa, M Debouverie, J De Seze, S Wiertlievski, B Brochet, P Clavelou, D Brassat, P Labauge, E Roullet, et al. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 195 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pelayo, M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, M. Comabella, and X. Montalban Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort Multiple Sclerosis, July 1, 2007; 13(6): 731 - 736. [Abstract] [PDF] |
||||
![]() |
B. Banwell, M. Shroff, J. M. Ness, D. Jeffery, S. Schwid, B. Weinstock-Guttman, and for the International Pediatric MS Study Group MRI features of pediatric multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S46 - S53. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Puccioni-Sohler, Y. Yamano, M. Rios, S.M.F. Carvalho, C. C.F. Vasconcelos, R. Papais-Alvarenga, and S. Jacobson Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I Neurology, January 16, 2007; 68(3): 206 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P. Wattjes, G.G. Lutterbey, J. Gieseke, F. Traber, L. Klotz, S. Schmidt, and H.H. Schild Double Inversion Recovery Brain Imaging at 3T: Diagnostic Value in the Detection of Multiple Sclerosis Lesions AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 54 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, and X. Montalban Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology, September 26, 2006; 67(6): 968 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imrell, A.-M. Landtblom, J. Hillert, and T. Masterman Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct. Neurology, September 26, 2006; 67(6): 1062 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P. Wattjes, M. Harzheim, C.K. Kuhl, J. Gieseke, S. Schmidt, L. Klotz, T. Klockgether, H.H. Schild, and G.G. Lutterbey Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis? AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1794 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 830 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inglese Multiple sclerosis: new insights and trends. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 954 - 957. [Full Text] [PDF] |
||||
![]() |
J Bruna, S Martinez-Yelamos, A Martinez-Yelamos, F Rubio, and T Arbizu Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases Multiple Sclerosis, April 1, 2006; 12(2): 169 - 173. [Abstract] [PDF] |
||||
![]() |
J. Masjuan, J. C. Alvarez-Cermeno, N. Garcia-Barragan, M. Diaz-Sanchez, M. Espino, M. C. Sadaba, P. Gonzalez-Porque, J. M. San Millan, and L. M. Villar Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS Neurology, February 28, 2006; 66(4): 576 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S A Trip and D H Miller Imaging in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(suppl_3): iii11 - iii18. [Full Text] [PDF] |
||||
![]() |
J Zajicek Diagnosis and disease modifying treatments in multiple sclerosis Postgrad. Med. J., September 1, 2005; 81(959): 556 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H Polman, J. S Wolinsky, and S. C Reingold Multiple sclerosis diagnostic criteria: three years later Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12. [Abstract] [PDF] |
||||
![]() |
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11. [Abstract] [Full Text] |
||||
![]() |
Y. Mikaeloff, C. Adamsbaum, B. Husson, L. Vallee, G. Ponsot, C. Confavreux, M. Tardieu, S. Suissa, and the KIDMUS Study Group on Radiology MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood Brain, September 1, 2004; 127(9): 1942 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort Neurology, March 9, 2004; 62(5): 806 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Goffette, M Schluep, H Henry, T Duprez, and C J M Sindic Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 308 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sastre-Garriga, M. Tintore, A. Rovira, C. Nos, J. Rio, A. J. Thompson, and X. Montalban Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes Arch Neurol, February 1, 2004; 61(2): 222 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination Neurology, January 27, 2004; 62(2): 226 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Dalton, P A Brex, K A Miszkiel, K Fernando, D G MacManus, G T Plant, A J Thompson, and D H Miller Spinal cord MRI in clinically isolated optic neuritis J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1577 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Simon and A. J. Thompson Is multiple sclerosis still a clinical diagnosis? Neurology, September 9, 2003; 61(5): 596 - 597. [Full Text] [PDF] |
||||
![]() |
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, September 9, 2003; 61(5): 602 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Villoslada, C. Juste, M. Tintore, V. Llorenc, G. Codina, P. Pozo-Rosich, and X. Montalban The immune response against herpesvirus is more prominent in the early stages of MS Neurology, June 24, 2003; 60(12): 1944 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Sastre-Garriga, M Tintore, A Rovira, E Grive, I Pericot, M Comabella, A J Thompson, and X Montalban C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings Multiple Sclerosis, February 1, 2003; 9(1): 39 - 43. [Abstract] [PDF] |
||||
![]() |
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, J. Sastre-Garriga, I. Pericot, E. Sanchez, M. Comabella, and X. Montalban New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode Neurology, January 14, 2003; 60(1): 27 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
CHAMPS Study Group MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group Neurology, October 8, 2002; 59(7): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O'Connor Key issues in the diagnosis and treatment of multiple sclerosis: An overview Neurology, September 24, 2002; 59(90063): S1 - 33. [Full Text] |
||||
![]() |
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58. [Abstract] [PDF] |
||||
![]() |
H. McFarland The emerging role of MRI in multiple sclerosis and the new diagnostic criteria Multiple Sclerosis, September 1, 2002; 8(1_suppl): 71 - 72. [PDF] |
||||
![]() |
L. M. Villar, J. Masjuan, P. Gonzalez-Porque, J. Plaza, M. C. Sadaba, E. Roldan, A. Bootello, and J. C. Alvarez-Cermeno Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS Neurology, August 27, 2002; 59(4): 555 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
CHAMPS Study Group Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338. [Abstract] [PDF] |
||||
![]() |
P Kapeller, P A Brex, D Chard, C Dalton, C M Griffin, M A McLean, G J. Parker, A J Thompson, and D H Miller Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis Multiple Sclerosis, June 1, 2002; 8(3): 207 - 210. [Abstract] [PDF] |
||||
![]() |
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58. [Abstract] [PDF] |
||||
![]() |
H F McFarland The emerging role of MRI in multiple sclerosis and the new diagnostic criteria Multiple Sclerosis, February 1, 2002; 8(1): 71 - 72. [PDF] |
||||
![]() |
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363. [Abstract] [PDF] |
||||
![]() |
R. C. Dale, C. de Sousa, W. K. Chong, T. C. S. Cox, B. Harding, and B. G. R. Neville Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children Brain, December 1, 2000; 123(12): 2407 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. J. Bot, F. Barkhof, G. L. a Nijeholt, D. van Schaardenburg, A. E. Voskuyl, H. J. Ader, J. A. L. Pijnenburg, C. H. Polman, B. M. J. Uitdehaag, E. G. J. Vermeulen, et al. Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging Radiology, April 1, 2002; 223(1): 46 - 56. [Abstract] [Full Text] [PDF] |
||||







